StockNews.com assumed coverage on shares of Elevance Health (NYSE:ELV – Get Rating) in a research report sent to investors on Thursday morning. The firm issued a strong-buy rating on the stock. Several other research firms also recently issued reports on ELV. Wells Fargo & Company cut their price objective on Elevance Health from $597.00 to […]